Adaptive Biotechnologies Corp [NASDAQ: ADPT] traded at a low on Tuesday, posting a -12.16 loss after which it closed the day’ session at $8.81.
The results of the trading session contributed to over 5512855 shares changing hands. Over the past one week, the price volatility of Adaptive Biotechnologies Corp stands at 11.11% while the volatility over the past one month is 9.35%.
The market cap for ADPT stock reached $1.34 billion, with 151.92 million shares outstanding and 144.92 million shares in the current float. Compared to the average trading volume of 2.35M shares, ADPT reached a trading volume of 5512855 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Adaptive Biotechnologies Corp [ADPT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ADPT shares is $11.14 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ADPT stock is a recommendation set at 1.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Adaptive Biotechnologies Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 21, 2025. While these analysts kept the previous recommendation, JP Morgan raised their target price to Overweight. The new note on the price target was released on July 05, 2023, representing the official price target for Adaptive Biotechnologies Corp stock. Previously, the target price had yet another raise to $15, while Scotiabank analysts kept a Sector Outperform rating on ADPT stock. On December 21, 2022, analysts increased their price target for ADPT shares from 7.50 to 14.
The Average True Range (ATR) for Adaptive Biotechnologies Corp is set at 0.80, with the Price to Sales ratio for ADPT stock in the period of the last 12 months amounting to 7.06. The Price to Book ratio for the last quarter was 7.03, with the Price to Cash per share for the same quarter was set at 1.27.
How has ADPT stock performed recently?
Adaptive Biotechnologies Corp [ADPT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.77. With this latest performance, ADPT shares gained by 17.94% in over the last four-week period, additionally plugging by 82.02% over the last 6 months – not to mention a rise of 200.68% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADPT stock in for the last two-week period is set at 57.00, with the RSI for the last a single of trading hit 57.80, and the three-weeks RSI is set at 56.04 for Adaptive Biotechnologies Corp [ADPT]. The present Moving Average for the last 50 days of trading for this stock 7.84, while it was recorded at 8.68 for the last single week of trading, and 6.20 for the last 200 days.
Adaptive Biotechnologies Corp [ADPT]: Deeper insight into the fundamentals
Adaptive Biotechnologies Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.82 and a Current Ratio set at 2.92.
Earnings analysis for Adaptive Biotechnologies Corp [ADPT]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ADPT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Adaptive Biotechnologies Corp go to 29.40%.
Insider trade positions for Adaptive Biotechnologies Corp [ADPT]
The top three institutional holders of ADPT stocks are: VIKING GLOBAL INVESTORS LP with ownership of 29.99 million shares, which is approximately 20.3466%. RUBRIC CAPITAL MANAGEMENT LP, holding 14.0 million shares of the stock with an approximate value of $$50.68 million in ADPT stocks shares; and RUBRIC CAPITAL MANAGEMENT LP, currently with $$42.22 million in ADPT stock with ownership which is approximately 7.9124%.
